To further address the underlying mechanisms of eIF4E phosphorylation in the etiology of depression, we showed that eFT508 treatment significantly rescued LPS-induced depressive-like behaviors, neuroinflammation, and synaptic protein dysregulations in the mice. This evidence concerns the gene EIF4E and depressive disorder.